https://www.selleckchem.com/pr....oducts/INCB18424.htm
Cirrhosis was present in 62% of patients, but under half of these patients had undergone imaging within 12 months of HCC diagnosis. Patients with cirrhosis were more likely to have early stage disease but less often received curative therapy. After adjustment, cirrhosis was not associated with prognosis, but the presence of cancer-related symptoms at diagnosis was associated with poorer prognosis. Conclusion Cirrhosis was not associated with overall survival in this cohort of MAFLD-related HCC, while diagnosis in the presence of sympt